The 11th Swedish-American Life Science Summit, taking place in Stockholm, Sweden, August 19-21st, will focus on Infectious Disease, Cancer Breakthroughs and Commercialization

The exclusive Life Science meeting enters a new decade with its 11th annual summit, focusing on Infectious Disease, Cancer Breakthroughs and Commercialization. Top scientists, investors, business executives and start-ups meet and discuss important issues, to initiate new partnerships and ventures.

Aug 18, 2015, 17:15 ET from Swedish-American Life Science Summit 2015

STOCKHOLM, Aug. 18, 2015 /PRNewswire/ -- The Swedish-American Life Science Summit (SALSS) announced today that this year's conference will focus on Infectious Disease, highlighting Antibiotic Resistance and Vaccines, the New Paradigm in Cancer Breakthroughs and how to improve Entrepreneurship and Commercialization.

From the start SALSS is meant to serve as a business platform, but also to provide insights to the future of Life Science and initiate new ideas and collaborations. "This year, I'm happy to feature so many bright and accomplished young entrepreneurs and women in the industry. In these times of change we need more successful entrepreneurs and women to secure the future of Life Science." says Barbro C. Ehnbom, Founder and Chairman.

"SALSS is a key instrument to highlight the best of science in Sweden and the United States, and to bring together researchers, developers and entrepreneurs across the Atlantic to discuss and challenge the field of life sciences and medicine" says Dr. Emmanuelle Charpentier, Professor, Helmholtz Centre for Infection Research.

The impressive list of speakers this year features among others Professor Hans Rosling, co-founder of the Gapminder Foundation and advisor to Liberia during the Ebola epidemic, Dr. Rino Rappuoli, Chief Scientist at GSK Vaccines, Emmanuelle Charpentier, one of Time's 100 Most Influential People in the World 2015 with her breakthrough genome engineering and Dr. Susan Galbraith, Head of Oncology Innovative Medicine at AstraZeneca.

ABOUT SALSS 2015 The Swedish-American Life Science Summit 2015 is the 11th annual Summit in an invitation-only format, with a program featuring some of the best known Life Science scientists, executives and investors in the world. The objective is to stimulate the Life Science sector in Sweden, paving the way for new investments and establishing Sweden as an international hub for Life Science. The Summit program includes panel discussions, keynote speeches and company presentations. Barbro C. Ehnbom, Founder and Chairman of SALSS, has been a pioneer in the Life Science industry throughout her whole career and is passionate about seeing the Swedish Life Science Sector prosper in collaboration with the business world.

For more information on SALSS, visit

SOURCE Swedish-American Life Science Summit 2015